This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Opinion: Reviewing the FDA approval of Abbott's AVEIR system, the first Dual Chamber Leadless Pacemaker

Ticker(s): ABT, MDT, BSX, BIOTRONIK

Who's the expert?

Institution: Brigham and Women's Hospital, Heart and Vascular Center

  • Cardiac Electrophysiologist and Instructor of Medicine at Harvard Medical School.
  • Treats over 350 patients with atrial fibrilation, 50 with recurrent pericarditis and 150 with PSVT.
  • Clinical interests include arrhythmias, atrial fibrillation, electrophysiology, and Cardiovascular genetics.

Interview Questions
Q1.

Describe your background and practice setting

Added By: ben_admin
Q2.

How many patients with heart arrhythmia issues do you currently manage?

Added By: ben_admin
Q3.

Which patients are candidates for a pacemaker?

Added By: ben_admin
Q4.

What is your opinion of the AVEIR pacemaker system?

Added By: ben_admin
Q5.

What % of your pacemaker cases will you utilize the Aveir system?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.